跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
MINT-FUROSEMIDE
Authorized
STANDARD
MINT-FUROSEMIDE
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2785b24d28b056eb
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
2785b24d28b056eb
Drug Approval Canada Name
MINT-FUROSEMIDE
Product Name
MINT-FUROSEMIDE
Status
Marketed
Status Date
2018-07-30
Original Market Date
2018-07-30
Din
02466775
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
40:28.08
Atc Original
C03CA01 FUROSEMIDE
Atc Name
c 03 ca 01
Aig Number
0101944004
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
FUROSEMIDE
80 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2785b24d28b056eb
Type
Standard
Back to Health Canada Approvals
MINT-FUROSEMIDE - Health Canada Drug Approval Details